Search clinical trials for: Skin condition, itching, psoriasis vulgaris, relapsing remitting psoriasis, immune-med systemic dise

Total 385087 results

Novartis Pharmaceuticals

Completed

Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque Psoriasis

Moderate to Severe Chronic Plaque-type Psoriasis

Belgium, Spain, Russian Federation, Germany, United States, Czechia, Peru, Poland, Estonia
Novartis Pharmaceuticals

Completed

Comparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic Syndrome (METABOLYX)

Psoriasis | Metabolic Syndrome

Germany
Novartis Pharmaceuticals

Completed

Secukinumab Dosage Optimisation in Partial Responders With Moderate to Severe Plaque-type Psoriasis (GAIN)

Moderate to Severe Plaque-type Psoriasis

Germany
Novartis Pharmaceuticals

Completed

Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis (IPSI-PSO)

Psoriasis

France
Novartis Pharmaceuticals

Completed

Judging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating Treatment Results (JUNCTURE) (JUNCTURE)

Plaque-type Psoriasis

Germany, United States, France, Estonia, Canada
Novartis Pharmaceuticals

Completed

Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Palmoplantar Psoriasis (GESTURE)

Moderate to Severe Palmoplantar Psoriasis

Belgium, United States, Hungary, Russian Federation, Turkey, Australia, Israel, Netherlands, Portugal, Spain, United Kingdom, Norway, Slovakia, Canada, Finland
RenJi Hospital
AbelZeta Pharma Inc.

Recruiting

A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy (CAR-AID)

Systemic Lupus Erythematosus (SLE) | Neuromyelitis Optica Spectrum Disorders | Immune-Mediated Necrotizing Myopathy | Multiple Sclerosis-Relapsing-Remitting

China
Novartis Pharmaceuticals

Completed

Efficacy and Safety of 2 Secukinumab Regimens in 90kg or More Weight Group With Moderate/Severe Chronic Plaque Psoriasis

Moderate to Severe Chronic Plaque-type Psoriasis

United States, Hungary, Italy, Russian Federation, Germany, Czechia, Canada
Novartis Pharmaceuticals

Completed

Comparison of Secukinumab Versus Guselkumab in Clearing Psoriatic Plaques Refractory to Ustekinumab (ARROW)

Chronic Plaque-type Psoriasis

Germany, United States, Canada
Eli Lilly and Company

Completed

A Study of Ixekizumab (LY2439821) in Chinese Participants With Moderate-to-Severe Plaque Psoriasis

Plaque Psoriasis

China
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of Secukinumab in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis

Plaque Psoriasis

China, Thailand, Philippines, Turkey, Hungary, Malaysia
Novartis Pharmaceuticals

Completed

A Study to Evaluate Clear Skin Effect on Quality of Life in Patients With Plaque Psoriasis. (PROSE)

Plaque Psoriasis

Germany, United Kingdom, Belgium, Czechia, Estonia, Italy, France, Israel, Spain, Bulgaria, Lithuania, Portugal, Poland, Romania, Latvia, Greece, Slovakia
University of Southern California
Teva Pharmaceuticals USA

Completed

Glatiramer Acetate for Multiple Sclerosis With Autoimmune Comorbidities

Relapsing Remitting Multiple Sclerosis

United States
University of Central Florida

Recruiting

Rheumatology Diet Study

Autoimmune Diseases | Rheumatoid Arthritis | Fibromyalgia | Psoriatic Arthritis | Sjogren's Syndrome | Diet Habit | Ankylosing Spondylitis | Scleroderma | Rheumatologic Disease | Systemic Lupus Erythematous | Dermatomyositis/Polymyositis

United States
AbbVie

Recruiting

A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout the Whole Body)

Moderate Plaque Psoriasis

United States
Novartis Pharmaceuticals

Recruiting

Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Psoriasis (SPARROW)

Moderate-to-severe Plaque Psoriasis

Russian Federation
University Hospital Schleswig-Holstein

Recruiting

Determinants of Chronic Inflammatory Skin Disease Trajectories

Psoriasis | Eczema | Atopic Dermatitis | Alopecia Areata | Lichen

Germany
Brigham and Women's Hospital
Bristol-Myers Squibb

Recruiting

Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity (RAISE)

Rheumatoid Arthritis | Systemic Sclerosis | Inflammatory Arthritis | Psoriatic Arthritis | Sjogren's Syndrome | Juvenile Rheumatoid Arthritis | Ankylosing Spondylitis | Undifferentiated Connective Tissue Diseases | Lupus | Sacroiliitis | Sicca Syndrome | Mixed Connective Tissue Disease | Palindromic Arthritis | Enteropathic...

United States
GlaxoSmithKline

Recruiting

Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA) (OCEAN)

Eosinophilic Granulomatosis With Polyangiitis

Canada, France, Italy, Spain, Belgium, Korea, Republic of, United States, Japan, China, Czechia, Hungary, Israel, Portugal, Poland, Netherlands, United Kingdom, Austria, Argentina, Australia, Brazil, Germany, Sweden
Centre of Evidence of the French Society of Dermatology

Recruiting

Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines

Psoriasis | Psoriasis Vulgaris | Psoriasis of Scalp | Psoriatic Plaque | Psoriasis Universalis | Psoriasis Palmaris | Psoriatic Erythroderma | Psoriatic Nail | Psoriasis Guttate | Psoriasis Inverse | Psoriasis Pustular

France
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

Melanoma | Rheumatoid Arthritis | Systemic Lupus Erythematosus | Psoriasis | Crohn Disease | Ulcerative Colitis | Psoriatic Arthritis | Inflammatory Bowel Disease | Autoimmune Disease | Ankylosing Spondylitis | Reactive Arthritis | Enteropathic Arthritis | Enteropathic Spondylitis

United States
Yale University
Rheumatology Research Foundation

Recruiting

Rheumatology Patient Registry and Biorepository

Rheumatic Diseases | Rheumatoid Arthritis | Systemic Lupus Erythematosus | Systemic Sclerosis | Dermatomyositis | Polymyositis | Giant Cell Arteritis | Polymyalgia Rheumatica | Psoriatic Arthritis | Sjogren's Syndrome | Antiphospholipid Syndrome | Sarcoidosis | Lyme Disease | Ankylosing Spondylitis | Scleroderma | Reactive... and other conditions

United States
University Hospital, Lille
FHU IMMINeNT; FHU PRECISE: Projet Fédératif Hospitalo-Universitaire PREcision... and other collaborators

Recruiting

Deployment o the Multidisciplinary Prospective Cohort Imminent (IMMINeNT)

Multiple Sclerosis | Systemic Sclerosis | Atopic Dermatitis | Psoriatic Arthritis | Angioedema | Severe Asthma | Behçet Disease | Lupus | Chronic Inflammatory Disease

France
Centre Hospitalier Universitaire de Besancon

Recruiting

Evolution and Treatments of Chronic Inflammatory Systemic Diseases (MISTIC)

Arthritis, Rheumatoid | Inflammatory Bowel Diseases | Psoriasis | Crohn Disease | Ulcerative Colitis | Psoriatic Arthritis | Spondyloarthritis | Verneuil's Disease

France
Global Healthy Living Foundation
University of Alabama at Birmingham

Recruiting

PatientSpot Formerly Known as ArthritisPower (GHLF)

Heart Failure | Stroke | Epilepsy | Multiple Sclerosis | Obesity | Diabetes | Chronic Obstructive Pulmonary Disease | Osteoarthritis | Rheumatoid Arthritis | Parkinson Disease | Peripheral Arterial Disease | Inflammatory Bowel Diseases | Amyotrophic Lateral Sclerosis | Psoriasis | Asthma | Muscular Dystrophy | Fibromyalgia | Alzheimer... and other conditions

United States
National Cancer Institute (NCI)

Recruiting

Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Multiple Sclerosis | Rheumatoid Arthritis | Systemic Lupus Erythematosus | Psoriasis | Systemic Scleroderma | Crohn Disease | Ulcerative Colitis | Dermatomyositis | Psoriatic Arthritis | Inflammatory Bowel Disease | Autoimmune Disease | Sjogren...

United States, Canada
Eli Lilly and Company

Recruiting

A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis (JUVE-X)

Juvenile Idiopathic Arthritis

Belgium, Spain, Australia, India, Japan, Italy, Czechia, Germany, Austria, France, United Kingdom, China, Mexico, Israel, Brazil, Denmark, Poland, Russian Federation, Argentina, Turkey
Assistance Publique - Hôpitaux de Paris

Recruiting

Study of Refractory and/or Relapsing TAkayasu aRTeritis (START)

Arteritis | Systemic Vasculitis | Arteritis, Takayasu

France
Assistance Publique - Hôpitaux de Paris
CRAT; SNFMI; SFR

Recruiting

Pregnancy and Medically Assisted Conception in Rare Diseases (EGR2)

Rheumatoid Arthritis | Systemic Lupus Erythematosus | Vasculitis | Myositis | Psoriatic Arthritis | Antiphospholipid Syndrome | Sjogren Syndrome | Spondyloarthritis | Mastocytosis | Scleroderma | Various Autoimmune and/or Systemic and/or Rare Diseases

France
Duke University
Childhood Arthritis and Rheumatology Research Alliance

Recruiting

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

Rheumatic Joint Disease

United States, Canada, Israel, Italy, Puerto Rico
National Institute of Arthritis and Musculoskeletal...

Recruiting

Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis

Giant Cell Arteritis | Polyarteritis Nodosa | Takayasu's Arteritis | ANCA-Associated Vasculitis | Relapsing Polychondritis

United States
Fundación Academia Española de Dermatología
Bristol-Myers Squibb; Eli Lilly and Company; UCB Pharma; Merck Sharp & Dohme LLC; Novarti... and other collaborators

Recruiting

Spanish Registry of Systemic Treatments in Psoriasis (Biobadaderm)

Psoriasis

Spain
Swiss Dermatology Network for Targeted Therapies

Recruiting

Swiss Dermatology Network of Targeted Therapies (SDNTT) (SDNTT)

Psoriasis

Switzerland
Amgen

Completed

Study to Evaluate the Benefits for the Patient Associated With the Treatment of Plaque Psoriasis With Apremilast After Other Systemic Treatment in Conditions of Clinical Practice in Spain (APPROPIATE)

Psoriasis

Spain
University of California, Irvine

Withdrawn

Evaluation of Vitamin D Levels in Psoriasis Patients

Psoriasis

United States
AbbVie

Completed

Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy

Psoriasis

United States, Canada, Germany, Israel, Poland
Janssen Scientific Affairs, LLC

Active, not recruiting

Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Psoriasis

United States, Australia, Ukraine, Belgium, Taiwan, Spain, Austria, Colombia, Israel, Portugal, Slovenia, Japan, Canada, Greece, Korea, Republic of, Argentina, Chile, Netherlands, Sweden, Slovakia, Czechia, Mexico
Sanguine Biosciences

Completed

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Depression | Melanoma | Epilepsy | Lymphoma | Multiple Sclerosis | Kidney Cancer | Cervical Cancer | Diabetes Mellitus | Leukemia | Breast Cancer | Chronic Kidney Diseases | Chronic Obstructive Pulmonary Disease | Parkinson's Disease | Systemic Lupus Erythematosus | Multiple Myeloma | Hepatitis B | Insomnia | Colorectal Cancer | HIV/AID... and other conditions

United States
Primus Pharmaceuticals
Prosoft Clinical

Terminated

Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06

Psoriasis

United States
University of Nottingham

Completed

Monitoring of Inflammatory Conditions

Rheumatoid Arthritis | Psoriasis | Crohn Disease | Inflammatory Arthritis | Ulcerative Colitis | Psoriatic Arthritis | Reactive Arthritis | Inflammatory Disease | System; Lupus Erythematosus

United Kingdom
Assistance Publique - Hôpitaux de Paris
Société de Dermatologie Française

Completed

Assessing the Long Term Effectiveness and Safety of Systemic Treatments in Cutaneous Psoriasis (PSOBIOTEQ)

Psoriasis

France
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis

Obesity | Psoriasis | Dyslipidemia | Atherosclerotic Cardiovascular Disease | Cardiometabolic Diseases

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Anti-Inflammatory Effects of Time-Restricted Feeding

Psoriasis | Systemic Inflammation

United States
University of Medicine and Pharmacy at Ho Chi Minh...

Completed

Periodontal Status in Patients With Chronic Skin Diseases

Periodontal Diseases | Systemic Lupus Erythematosus | Psoriasis | Atopic Dermatitis | Autoimmune Bullous Dermatosis

Vietnam
Cambridge University Hospitals NHS Foundation Trust

Active, not recruiting

Biologics in Refractory Vasculitis (BIOVAS)

Giant Cell Arteritis | Polyarteritis Nodosa | Takayasu Arteritis | Cryoglobulinemic Vasculitis | IgA Vasculitis | Cogan Syndrome | Relapsing Polychondritis | Cutaneous Polyarteritis Nodosa | Primary Angiitis of Central Nervous System

United Kingdom
University of South Florida
Bristol-Myers Squibb; University of Pennsylvania; National Institute of Arthritis... and other collaborators

Active, not recruiting

Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)

Wegener's Granulomatosis | Granulomatosis With Polyangiitis | ANCA-Associated Vasculitis | Granulomatosis With Polyangiitis (Wegener's)

United States, United Kingdom, Ireland, Canada, Germany
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of Secukinumab in Chinese Subjects With Active PsA Compared to Placebo.

Psoriatic Arthritis

China
Novartis Pharmaceuticals

Completed

Characteristics of Patients Treated With Secukinumab for Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

Thailand
Innovaderm Research Inc.
Ciusss de L'Est de l'Île de Montréal

Withdrawn

Effect of Bimekizumab in Patients With Psoriasis Vulgaris and Active Psoriatic Arthritis

Psoriasis Vulgaris | Active Psoriatic Arthritis
Alliance Foundation Trials, LLC.
Bristol-Myers Squibb

Terminated

Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease

Multiple Sclerosis | Autoimmune Diseases | Rheumatoid Arthritis | Systemic Lupus Erythematosus | Psoriasis | Crohn Disease | Ulcerative Colitis | Non-small Cell Lung Cancer | Giant Cell Arteritis | Polymyalgia Rheumatica

United States

Search clinical trials for: Skin condition, itching, psoriasis vulgaris, relapsing remitting psoriasis, immune-med systemic dise

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations